Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes
ContributorsGencer, Baris; Rigamonti, Fabio; Nanchen, David; Vuilleumier, Nicolas; Kern, Ilse; Aghlmandi, Soheila; Klingenberg, Roland; Räber, Lorenz; Auer, Reto; Carballo, David; Carballo, Juan Sebastian
Published inEuropean Journal of Clinical Investigation, vol. 49, no. 7, e13117
Publication date2019
Abstract
Affiliation entities
Funding
- Swiss National Science Foundation - Inflammation and acute coronary syndrome (ACS) - novel strategies for prevention and clinical management [124112]
- Swiss National Science Foundation - Inflammation and acute coronary syndrome (ACS) - novel strategies for prevention and clinical management [140336]
- Swiss National Science Foundation - Long-term Benefit of the Multi-Center, Multi-Dimensional Secondary Prevention Program in Patients With Acute Coronary Syndromes [163271]
- Swiss National Science Foundation - Novel biomarkers and skeletal outcomes associated with subclinical thyroid dysfunction: a prospective evaluation and impact of treatment [150025]
Citation (ISO format)
GENCER, Baris et al. Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes. In: European Journal of Clinical Investigation, 2019, vol. 49, n° 7, p. e13117. doi: 10.1111/eci.13117
Main files (1)
Article (Published version)
Identifiers
- PID : unige:121600
- DOI : 10.1111/eci.13117
- PMID : 30937890
Journal ISSN0014-2972
